These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38680087)

  • 1. Follow-up for human papillomavirus-related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient-reported outcome collection.
    Edwards DM; Gharzai LA; Wang W; Mayo C; Suresh K; Schipper M; Evans JR; Malloy K; Chinn SB; Prince M; Spector M; Shuman A; Stucken C; Swiecicki PL; Worden F; Jarema J; Henderson C; Kovach A; Brenner C; Shah JL; Mierzwa ML; Casper K
    Head Neck; 2024 Nov; 46(11):2687-2698. PubMed ID: 38680087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.
    Chera BS; Kumar S; Shen C; Amdur R; Dagan R; Green R; Goldman E; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman T; Blumberg J; Patel S; Thorp B; Weissler M; Yarbrough W; Sheets N; Mendenhall W; Tan XM; Gupta GP
    J Clin Oncol; 2020 Apr; 38(10):1050-1058. PubMed ID: 32017652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
    Veyer D; Wack M; Mandavit M; Garrigou S; Hans S; Bonfils P; Tartour E; Bélec L; Wang-Renault SF; Laurent-Puig P; Mirghani H; Rance B; Taly V; Badoual C; Péré H
    Int J Cancer; 2020 Aug; 147(4):1222-1227. PubMed ID: 31756275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy - a feasibility study.
    Taarnhøj GA; Lindberg H; Dohn LH; Omland LH; Hjøllund NH; Johansen C; Pappot H
    Health Qual Life Outcomes; 2020 Jul; 18(1):225. PubMed ID: 32653005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer.
    Regan SN; Mierzwa ML
    Cancer J; 2023 Jul-Aug 01; 29(4):226-229. PubMed ID: 37471613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of circulating tumor DNA by targeting human papilloma virus-derived sequences as a biomarker in p16-positive oropharyngeal cancer.
    Akashi K; Sakai T; Fukuoka O; Saito Y; Yoshida M; Ando M; Ito T; Murakami Y; Yamasoba T
    Sci Rep; 2022 Jan; 12(1):572. PubMed ID: 35022425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient motivators of postoperative electronic patient-reported outcome symptom monitoring use in thoracic surgery patients: a qualitative study.
    O'Leary MC; Kwong E; Cox C; Gentry AL; Stover AM; Vu MB; Carda-Auten J; Leeman J; Mody GN
    J Patient Rep Outcomes; 2024 Jul; 8(1):81. PubMed ID: 39060464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood and saliva-derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus-associated head and neck cancer.
    Ferrier ST; Tsering T; Sadeghi N; Zeitouni A; Burnier JV
    Cancer Med; 2023 Aug; 12(15):15777-15787. PubMed ID: 37526056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer.
    Ahn SM; Chan JY; Zhang Z; Wang H; Khan Z; Bishop JA; Westra W; Koch WM; Califano JA
    JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):846-54. PubMed ID: 25078109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer.
    Han K; Zou J; Zhao Z; Baskurt Z; Zheng Y; Barnes E; Croke J; Ferguson SE; Fyles A; Gien L; Gladwish A; Lecavalier-Barsoum M; Lheureux S; Lukovic J; Mackay H; Marchand EL; Metser U; Milosevic M; Taggar AS; Bratman SV; Leung E
    J Clin Oncol; 2024 Feb; 42(4):431-440. PubMed ID: 37972346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive impact of human papillomavirus circulating tumor DNA in treatment response monitoring of HPV-associated cancers; a meta-analysis on recurrent event endpoints.
    Karimi A; Jafari-Koshki T; Zehtabi M; Kargar F; Gheit T
    Cancer Med; 2023 Sep; 12(17):17592-17602. PubMed ID: 37492996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
    Frakes JM; Naghavi AO; Demetriou SK; Strom TJ; Russell JS; Kish JA; McCaffrey JC; Otto KJ; Padhya TA; Harrison LB; Trotti AM; Caudell JJ
    Cancer; 2016 Feb; 122(4):634-41. PubMed ID: 26565997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA.
    Leung E; Han K; Zou J; Zhao Z; Zheng Y; Wang TT; Rostami A; Siu LL; Pugh TJ; Bratman SV
    Clin Cancer Res; 2021 Nov; 27(21):5857-5868. PubMed ID: 34580115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer.
    Ferrandino RM; Chen S; Kappauf C; Barlow J; Gold BS; Berger MH; Westra WH; Teng MS; Khan MN; Posner MR; Misiukiewicz KJ; Bakst RL; Sindhu KK; Genden EM; Chai RL; Roof SA
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):971-977. PubMed ID: 37422913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.
    Hanna GJ; Roof SA; Jabalee J; Rettig EM; Ferrandino R; Chen S; Posner MR; Misiukiewicz KJ; Genden EM; Chai RL; Sims J; Thrash E; Stern SJ; Kalman NS; Yarlagadda S; Raben A; Clements L; Mendelsohn A; Kaczmar JM; Pandey Y; Bhayani M; Gupta P; Kuperwasser C; Del Vecchio Fitz C; Berger BM
    Clin Cancer Res; 2023 Oct; 29(20):4306-4313. PubMed ID: 37566241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal assessment of real-world patient adherence: a 12-month electronic patient-reported outcomes follow-up of women with early breast cancer undergoing treatment.
    Gebert P; Hage AM; Blohmer JU; Roehle R; Karsten MM
    Support Care Cancer; 2024 May; 32(6):344. PubMed ID: 38740611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a high-performance multi-probe droplet digital PCR assay for high-sensitivity detection of human papillomavirus circulating tumor DNA from plasma.
    Bhambhani C; Sandford E; Haring CT; Brummel C; Tuck KL; Olesnavich M; Bhangale AD; Walline HM; Dermody SM; Spector ME; Chinn SB; Casper K; Mierzwa M; Swiecicki PL; Chad Brenner J; Tewari M
    Oral Oncol; 2023 Aug; 143():106436. PubMed ID: 37269557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas.
    Melkane AE; Auperin A; Saulnier P; Lacroix L; Vielh P; Casiraghi O; Msakni I; Drusch F; Temam S
    Head Neck; 2014 Feb; 36(2):257-65. PubMed ID: 23728782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV-Related Oropharyngeal Cancer.
    Gharzai LA; Burger N; Li P; Jaworski EM; Henderson C; Spector M; Rosko A; Chen MM; Prince ME; Bradford CR; Malloy KM; Stucken CL; Swiecicki P; Worden F; Schipper MJ; Schonewolf CA; Shah J; Jagsi R; Chinn S; Shuman A; Casper K; Mierzwa ML
    Oncologist; 2021 Aug; 26(8):676-684. PubMed ID: 33823077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.